![](https://webarchive.library.unt.edu/eot2008/20090511034241im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20090511034241im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090511034241im_/http://www.cancer.gov/images/spacer.gif)
| Término que se refiere a las fases iniciales de la leucemia mielógena crónica o la leucemia linfocítica crónica. El número de glóbulos blancos anormales maduros e inmaduros en la médula ósea y la sangre es superior a lo normal, pero inferior al de la fase acelerada o la fase blástica. |
![](https://webarchive.library.unt.edu/eot2008/20090511034241im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090511034241im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20090511034241im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20090511034241im_/http://www.cancer.gov/images/spacer.gif) |